FDA Inspection 1280953 — Boston IVF Fertility Services at The Women's Hospital, LLC

Boston IVF Fertility Services at The Women's Hospital, LLC — FEI 3010149285

The FDA completed an inspection of Boston IVF Fertility Services at The Women's Hospital, LLC on September 9, 2025 in Newburgh, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 9, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Newburgh, IN (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence